Innophos Holdings, Inc. (NASDAQ:IPHS) – Analysts at KeyCorp issued their FY2018 earnings per share (EPS) estimates for shares of Innophos Holdings in a research note issued on Friday. KeyCorp analyst M. Sison expects that the specialty chemicals company will post earnings of $2.65 per share for the year.
IPHS has been the topic of a number of other reports. Sidoti upgraded shares of Innophos Holdings from a “neutral” rating to a “buy” rating in a research report on Friday, May 26th. They noted that the move was a valuation call. Zacks Investment Research upgraded shares of Innophos Holdings from a “sell” rating to a “hold” rating in a research report on Tuesday, July 11th. Finally, BidaskClub lowered shares of Innophos Holdings from a “hold” rating to a “sell” rating in a research report on Wednesday, July 12th.
Shares of Innophos Holdings (IPHS) traded up 0.49% during trading on Monday, reaching $47.54. 24,627 shares of the company’s stock were exchanged. Innophos Holdings has a 52-week low of $37.02 and a 52-week high of $58.22. The company has a 50 day moving average price of $43.53 and a 200-day moving average price of $47.20. The company has a market capitalization of $922.09 million, a PE ratio of 20.76 and a beta of 0.85.
Innophos Holdings (NASDAQ:IPHS) last issued its earnings results on Tuesday, August 1st. The specialty chemicals company reported $0.57 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.52 by $0.05. Innophos Holdings had a net margin of 6.46% and a return on equity of 13.79%. The firm had revenue of $179.14 million for the quarter, compared to analysts’ expectations of $172.65 million. During the same quarter last year, the company posted $0.63 earnings per share. Innophos Holdings’s revenue was down 1.5% on a year-over-year basis.
The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 6th. Shareholders of record on Friday, August 18th will be paid a $0.48 dividend. This represents a $1.92 annualized dividend and a yield of 4.06%. The ex-dividend date of this dividend is Wednesday, August 16th. Innophos Holdings’s payout ratio is presently 84.21%.
Several large investors have recently modified their holdings of the company. BNP Paribas Arbitrage SA increased its stake in shares of Innophos Holdings by 2.5% in the first quarter. BNP Paribas Arbitrage SA now owns 5,836 shares of the specialty chemicals company’s stock valued at $315,000 after buying an additional 142 shares in the last quarter. Bank of New York Mellon Corp increased its stake in shares of Innophos Holdings by 5.3% in the first quarter. Bank of New York Mellon Corp now owns 366,558 shares of the specialty chemicals company’s stock valued at $19,782,000 after buying an additional 18,421 shares in the last quarter. US Bancorp DE increased its stake in shares of Innophos Holdings by 13.9% in the first quarter. US Bancorp DE now owns 13,968 shares of the specialty chemicals company’s stock valued at $754,000 after buying an additional 1,703 shares in the last quarter. Boston Partners increased its stake in shares of Innophos Holdings by 2.2% in the first quarter. Boston Partners now owns 172,336 shares of the specialty chemicals company’s stock valued at $9,301,000 after buying an additional 3,690 shares in the last quarter. Finally, Capital Fund Management S.A. bought a new stake in shares of Innophos Holdings during the first quarter valued at about $1,430,000. 93.82% of the stock is owned by institutional investors.
Innophos Holdings Company Profile
Innophos Holdings, Inc is a producer of nutritional specialty ingredients with applications in food, beverage, dietary supplements, pharmaceutical, oral care and industrial end markets. The Company also provides bioactive mineral and nutritional ingredients. The Company’s segments include Specialty Phosphates US & Canada, Specialty Phosphates Mexico, and Granular Triple Super Phosphate (GTSP) & Other.
What are top analysts saying about Innophos Holdings Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Innophos Holdings Inc. and related companies.